HEADER TRANSFERASE 02-APR-20 6YJC TITLE CRYSTAL STRUCTURE OF P38ALPHA IN COMPLEX WITH SR154 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 14; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MAPK 14,CRK1,MITOGEN-ACTIVATED PROTEIN KINASE P38 ALPHA,MAP COMPND 5 KINASE P38 ALPHA; COMPND 6 EC: 2.7.11.24; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: MAPK14, CRK1, CSBP1, CSBP2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS KINASE, INHIBITOR, MAPK14, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS KEYWDS 2 CONSORTIUM, SGC, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR A.C.JOERGER,M.SCHROEDER,S.ROEHM,S.KNAPP,STRUCTURAL GENOMICS AUTHOR 2 CONSORTIUM (SGC) REVDAT 3 24-JAN-24 6YJC 1 REMARK REVDAT 2 21-OCT-20 6YJC 1 JRNL REVDAT 1 15-JUL-20 6YJC 0 JRNL AUTH S.ROHM,M.SCHRODER,J.E.DWYER,C.S.WIDDOWSON,A.CHAIKUAD, JRNL AUTH 2 B.T.BERGER,A.C.JOERGER,A.KRAMER,J.HARBIG,D.DAUCH,M.KUDOLO, JRNL AUTH 3 S.LAUFER,M.C.BAGLEY,S.KNAPP JRNL TITL SELECTIVE TARGETING OF THE ALPHA C AND DFG-OUT POCKET IN P38 JRNL TITL 2 MAPK. JRNL REF EUR.J.MED.CHEM. V. 208 12721 2020 JRNL REFN ISSN 0223-5234 JRNL PMID 33035818 JRNL DOI 10.1016/J.EJMECH.2020.112721 REMARK 2 REMARK 2 RESOLUTION. 1.74 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.10.1_2155 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.74 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 51.30 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.338 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 3 NUMBER OF REFLECTIONS : 37643 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.203 REMARK 3 R VALUE (WORKING SET) : 0.202 REMARK 3 FREE R VALUE : 0.237 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.986 REMARK 3 FREE R VALUE TEST SET COUNT : 1877 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 51.2990 - 4.0931 0.99 2973 112 0.1965 0.1651 REMARK 3 2 4.0931 - 3.2489 1.00 2878 103 0.1782 0.1886 REMARK 3 3 3.2489 - 2.8383 0.99 2822 131 0.2046 0.2750 REMARK 3 4 2.8383 - 2.5788 0.99 2755 149 0.1990 0.2276 REMARK 3 5 2.5788 - 2.3940 0.99 2753 153 0.1984 0.2756 REMARK 3 6 2.3940 - 2.2528 0.99 2708 194 0.2101 0.2572 REMARK 3 7 2.2528 - 2.1400 0.99 2712 163 0.2101 0.2785 REMARK 3 8 2.1400 - 2.0468 0.99 2749 133 0.2004 0.2340 REMARK 3 9 2.0468 - 1.9680 0.99 2726 126 0.2051 0.2764 REMARK 3 10 1.9680 - 1.9001 0.98 2739 126 0.2238 0.2653 REMARK 3 11 1.9001 - 1.8407 0.99 2710 150 0.2313 0.2539 REMARK 3 12 1.8407 - 1.7881 0.99 2672 167 0.2370 0.2487 REMARK 3 13 1.7881 - 1.7411 0.95 2569 170 0.2684 0.3138 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.204 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.368 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 20.64 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 2790 REMARK 3 ANGLE : 0.725 3796 REMARK 3 CHIRALITY : 0.047 425 REMARK 3 PLANARITY : 0.005 484 REMARK 3 DIHEDRAL : 16.487 1671 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6YJC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 03-APR-20. REMARK 100 THE DEPOSITION ID IS D_1292107642. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-APR-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.89429 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 130 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37702 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.740 REMARK 200 RESOLUTION RANGE LOW (A) : 51.300 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 5.100 REMARK 200 R MERGE (I) : 0.06900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.74 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.84 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.2 REMARK 200 DATA REDUNDANCY IN SHELL : 4.90 REMARK 200 R MERGE FOR SHELL (I) : 0.50900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5LAR REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.15 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15% MEDIUM MW PEG SMEAR, 0.1 M MES, PH REMARK 280 6.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 34.57000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 37.52000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.14500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 37.52000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 34.57000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.14500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 230 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16610 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 2.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 GLN A 3 REMARK 465 LEU A 171 REMARK 465 ALA A 172 REMARK 465 ARG A 173 REMARK 465 HIS A 174 REMARK 465 THR A 175 REMARK 465 ASP A 176 REMARK 465 ASP A 177 REMARK 465 GLU A 178 REMARK 465 MET A 179 REMARK 465 THR A 180 REMARK 465 GLY A 181 REMARK 465 TYR A 182 REMARK 465 LEU A 353 REMARK 465 ASP A 354 REMARK 465 GLN A 355 REMARK 465 GLU A 356 REMARK 465 GLU A 357 REMARK 465 MET A 358 REMARK 465 GLU A 359 REMARK 465 SER A 360 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 4 CG CD OE1 OE2 REMARK 470 ARG A 5 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 10 CG CD NE CZ NH1 NH2 REMARK 470 LEU A 13 C O CB CG CD1 CD2 REMARK 470 ASN A 14 N CA CB CG OD1 ND2 REMARK 470 LYS A 15 CG CD CE NZ REMARK 470 THR A 16 OG1 CG2 REMARK 470 GLU A 98 CG CD OE1 OE2 REMARK 470 ASN A 115 CG OD1 ND2 REMARK 470 LYS A 118 CG CD CE NZ REMARK 470 ARG A 186 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 264 CG CD OE1 NE2 REMARK 470 MET A 265 CG SD CE REMARK 470 LYS A 267 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 100 -2.62 -145.35 REMARK 500 ARG A 149 -12.12 81.20 REMARK 500 ASP A 150 46.73 -140.24 REMARK 500 MET A 198 -39.17 83.87 REMARK 500 GLN A 264 -67.75 -170.33 REMARK 500 PRO A 266 176.54 -58.95 REMARK 500 PHE A 274 69.03 -103.45 REMARK 500 LEU A 289 40.78 -103.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OSZ A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 402 DBREF 6YJC A 1 360 UNP P47811 MK14_MOUSE 1 360 SEQADV 6YJC GLY A 0 UNP P47811 EXPRESSION TAG SEQRES 1 A 361 GLY MET SER GLN GLU ARG PRO THR PHE TYR ARG GLN GLU SEQRES 2 A 361 LEU ASN LYS THR ILE TRP GLU VAL PRO GLU ARG TYR GLN SEQRES 3 A 361 ASN LEU SER PRO VAL GLY SER GLY ALA TYR GLY SER VAL SEQRES 4 A 361 CYS ALA ALA PHE ASP THR LYS THR GLY HIS ARG VAL ALA SEQRES 5 A 361 VAL LYS LYS LEU SER ARG PRO PHE GLN SER ILE ILE HIS SEQRES 6 A 361 ALA LYS ARG THR TYR ARG GLU LEU ARG LEU LEU LYS HIS SEQRES 7 A 361 MET LYS HIS GLU ASN VAL ILE GLY LEU LEU ASP VAL PHE SEQRES 8 A 361 THR PRO ALA ARG SER LEU GLU GLU PHE ASN ASP VAL TYR SEQRES 9 A 361 LEU VAL THR HIS LEU MET GLY ALA ASP LEU ASN ASN ILE SEQRES 10 A 361 VAL LYS CYS GLN LYS LEU THR ASP ASP HIS VAL GLN PHE SEQRES 11 A 361 LEU ILE TYR GLN ILE LEU ARG GLY LEU LYS TYR ILE HIS SEQRES 12 A 361 SER ALA ASP ILE ILE HIS ARG ASP LEU LYS PRO SER ASN SEQRES 13 A 361 LEU ALA VAL ASN GLU ASP CYS GLU LEU LYS ILE LEU ASP SEQRES 14 A 361 PHE GLY LEU ALA ARG HIS THR ASP ASP GLU MET THR GLY SEQRES 15 A 361 TYR VAL ALA THR ARG TRP TYR ARG ALA PRO GLU ILE MET SEQRES 16 A 361 LEU ASN TRP MET HIS TYR ASN GLN THR VAL ASP ILE TRP SEQRES 17 A 361 SER VAL GLY CYS ILE MET ALA GLU LEU LEU THR GLY ARG SEQRES 18 A 361 THR LEU PHE PRO GLY THR ASP HIS ILE ASP GLN LEU LYS SEQRES 19 A 361 LEU ILE LEU ARG LEU VAL GLY THR PRO GLY ALA GLU LEU SEQRES 20 A 361 LEU LYS LYS ILE SER SER GLU SER ALA ARG ASN TYR ILE SEQRES 21 A 361 GLN SER LEU ALA GLN MET PRO LYS MET ASN PHE ALA ASN SEQRES 22 A 361 VAL PHE ILE GLY ALA ASN PRO LEU ALA VAL ASP LEU LEU SEQRES 23 A 361 GLU LYS MET LEU VAL LEU ASP SER ASP LYS ARG ILE THR SEQRES 24 A 361 ALA ALA GLN ALA LEU ALA HIS ALA TYR PHE ALA GLN TYR SEQRES 25 A 361 HIS ASP PRO ASP ASP GLU PRO VAL ALA ASP PRO TYR ASP SEQRES 26 A 361 GLN SER PHE GLU SER ARG ASP LEU LEU ILE ASP GLU TRP SEQRES 27 A 361 LYS SER LEU THR TYR ASP GLU VAL ILE SER PHE VAL PRO SEQRES 28 A 361 PRO PRO LEU ASP GLN GLU GLU MET GLU SER HET OSZ A 401 42 HET EDO A 402 4 HETNAM OSZ 5-AZANYL-~{N}-[[4-[[(2~{S})-4-CYCLOHEXYL-1- HETNAM 2 OSZ OXIDANYLIDENE-1-PIPERAZIN-1-YL-BUTAN-2- HETNAM 3 OSZ YL]CARBAMOYL]PHENYL]METHYL]-1-PHENYL-PYRAZOLE-4- HETNAM 4 OSZ CARBOXAMIDE HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 2 OSZ C32 H41 N7 O3 FORMUL 3 EDO C2 H6 O2 FORMUL 4 HOH *256(H2 O) HELIX 1 AA1 SER A 61 MET A 78 1 18 HELIX 2 AA2 SER A 95 PHE A 99 5 5 HELIX 3 AA3 LEU A 113 LYS A 118 1 6 HELIX 4 AA4 THR A 123 ALA A 144 1 22 HELIX 5 AA5 LYS A 152 SER A 154 5 3 HELIX 6 AA6 ALA A 190 LEU A 195 1 6 HELIX 7 AA7 THR A 203 GLY A 219 1 17 HELIX 8 AA8 ASP A 227 GLY A 240 1 14 HELIX 9 AA9 GLY A 243 LYS A 248 1 6 HELIX 10 AB1 SER A 252 ALA A 263 1 12 HELIX 11 AB2 ASN A 269 VAL A 273 5 5 HELIX 12 AB3 ASN A 278 LEU A 289 1 12 HELIX 13 AB4 ASP A 292 ARG A 296 5 5 HELIX 14 AB5 THR A 298 ALA A 304 1 7 HELIX 15 AB6 HIS A 305 ALA A 309 5 5 HELIX 16 AB7 GLN A 325 ARG A 330 5 6 HELIX 17 AB8 LEU A 333 SER A 347 1 15 SHEET 1 AA1 2 PHE A 8 GLU A 12 0 SHEET 2 AA1 2 ILE A 17 PRO A 21 -1 O TRP A 18 N GLN A 11 SHEET 1 AA2 5 TYR A 24 PRO A 29 0 SHEET 2 AA2 5 VAL A 38 ASP A 43 -1 O PHE A 42 N GLN A 25 SHEET 3 AA2 5 HIS A 48 LYS A 54 -1 O VAL A 52 N CYS A 39 SHEET 4 AA2 5 TYR A 103 HIS A 107 -1 O LEU A 104 N LYS A 53 SHEET 5 AA2 5 ASP A 88 PHE A 90 -1 N ASP A 88 O VAL A 105 SHEET 1 AA3 3 ALA A 111 ASP A 112 0 SHEET 2 AA3 3 LEU A 156 VAL A 158 -1 O VAL A 158 N ALA A 111 SHEET 3 AA3 3 LEU A 164 ILE A 166 -1 O LYS A 165 N ALA A 157 SITE 1 AC1 14 TYR A 35 VAL A 38 ALA A 51 LYS A 53 SITE 2 AC1 14 GLU A 71 THR A 106 HIS A 107 MET A 109 SITE 3 AC1 14 GLY A 110 ASP A 168 PHE A 169 GLY A 170 SITE 4 AC1 14 HOH A 592 HOH A 625 SITE 1 AC2 4 LYS A 79 HIS A 80 HOH A 567 HOH A 615 CRYST1 69.140 70.290 75.040 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014463 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014227 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013326 0.00000